Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$6.52 - $8.95 $6,194 - $8,502
-950 Reduced 7.57%
11,600 $87,000
Q2 2022

Aug 03, 2022

BUY
$10.22 - $13.94 $1,022 - $1,394
100 Added 0.8%
12,550 $149,000
Q1 2022

May 04, 2022

SELL
$5.22 - $11.78 $261 - $589
-50 Reduced 0.4%
12,450 $140,000
Q4 2021

Jan 27, 2022

SELL
$5.37 - $8.38 $81,516 - $127,208
-15,180 Reduced 54.84%
12,500 $81,000
Q3 2021

Oct 29, 2021

BUY
$7.36 - $13.67 $19,872 - $36,909
2,700 Added 10.81%
27,680 $211,000
Q2 2021

Jul 26, 2021

BUY
$8.42 - $13.96 $94,977 - $157,468
11,280 Added 82.34%
24,980 $316,000
Q1 2021

Apr 27, 2021

BUY
$3.2 - $16.51 $8,000 - $41,275
2,500 Added 22.32%
13,700 $178,000
Q3 2020

Nov 06, 2020

SELL
$3.03 - $5.48 $6,363 - $11,508
-2,100 Reduced 15.79%
11,200 $44,000
Q2 2020

Jul 23, 2020

SELL
$3.53 - $6.17 $1,941 - $3,393
-550 Reduced 3.97%
13,300 $70,000
Q1 2020

Apr 30, 2020

SELL
$3.53 - $12.21 $19,591 - $67,765
-5,550 Reduced 28.61%
13,850 $57,000
Q4 2019

Jan 21, 2020

SELL
$11.58 - $17.37 $29,529 - $44,293
-2,550 Reduced 11.62%
19,400 $236,000
Q3 2019

Oct 29, 2019

SELL
$13.91 - $19.87 $36,861 - $52,655
-2,650 Reduced 10.77%
21,950 $343,000
Q2 2019

Jul 29, 2019

BUY
$13.19 - $28.36 $23,082 - $49,630
1,750 Added 7.66%
24,600 $360,000
Q1 2019

Apr 30, 2019

BUY
$12.43 - $28.91 $114,231 - $265,682
9,190 Added 67.28%
22,850 $516,000
Q4 2018

Feb 01, 2019

BUY
$10.57 - $19.29 $144,386 - $263,501
13,660 New
13,660 $163,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.